| CAS NO: | 1190389-15-1 |
| 规格: | ≥98% |
| 包装 | 价格(元) |
| 50mg | 电议 |
| 100mg | 电议 |
| 250mg | 电议 |
Vibegron (also known as KRP-114V; MK-4618; trade name Gemtesa) is a novel and potent β3 adrenergic receptor agonist approved in 2020 for the treatment of overactive bladder, which is a condition in which the bladder muscles contract uncontrollably and cause frequent urination.
纯度：≥98%
CAS：1190389-15-1
m.cnreagent.com